2025-04-08 18:23:00
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Bafna Pharmaceuticals Ltd Q4 FY2022 loss at Rs. 1.01 crore
Posted On : 2022-05-26 18:53:40( TIMEZONE : IST )
Bafna Pharmaceuticals Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 16.2508 crores during the period ended March 31, 2022 as compared to Rs. 20.9473 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -1.0150 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.7028 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -0.38 for the period ended March 31, 2022 as compared to Rs. 0.72 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 16.2508 crs | ₹20.9473 crs |  -22.42% |
| Net Profit | ₹-1.0150 crs | ₹1.7028 crs | -159.61% |
| EPS | ₹-0.38 | ₹0.72 | -152.78% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 16.2508 crores during the period ended March 31, 2022 as compared to Rs.22.1481 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-1.0150 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.2.6360 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-0.38 for the period ended March 31, 2022 as compared to Rs.1.11 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 16.2508 crs | ₹22.1481 crs | -26.63% |
| Net Profit | ₹-1.0150 crs | ₹2.6360 crs | -138.51% |
| EPS | ₹-0.38 | ₹1.11 | -134.23% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.87.2424 crores during the Financial Year ended March 31, 2022 as compared to Rs.71.9672 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.5.1511 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.5.8267 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.2.17 for the Financial Year ended March 31, 2022 as compared to Rs.2.46 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹87.2424 crs | ₹71.9672 crs |  21.23% |
| Net Profit | ₹5.1511 crs | ₹5.8267 crs | -11.59% |
| EPS | ₹2.17 | ₹2.46 | -11.79% |
Shares of Bafna Pharmaceuticals Limited was last trading in BSE at Rs. 116.40 as compared to the previous close of Rs. 120.50. The total number of shares traded during the day was 1147 in over 21 trades.
The stock hit an intraday high of Rs. 126.00 and intraday low of 114.50. The net turnover during the day was Rs. 134165.00.
